Bond.az White LogoBond.az Black Logo

#immix-biopharma

Latest news and interesting information about immix-biopharma.

Today / 10:24
|
364

Immix Biopharma reports 95% complete response rate in trial

Immix Biopharma's NEXICART-2 trial achieves 95% complete response rate in AL Amyloidosis patients. Promising results for CAR-T therapy NXC-201.

0
...